Andreas Karakatsanis

Expression of microRNAs, miR‐21, miR‐31, miR‐122, miR‐145, miR‐146a, miR‐200c, miR‐221, miR‐222, and miR‐223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its prognostic significance

Andreas Karakatsanis, Ioannis Papaconstantinou, Maria Gazouli et al. · Molecular Carcinogenesis · 2011 · 345 citations · Full text

Medicine, Cancer Biology, Oncology +17

The Nordic SentiMag trial: a comparison of super paramagnetic iron oxide (SPIO) nanoparticles versus Tc99 and patent blue in the detection of sentinel node (SN) in patients with breast cancer and a meta-analysis of earlier studies

Andreas Karakatsanis, Peer Christiansen, Lone Fischer et al. · Breast Cancer Research and Treatment · 2016 · 143 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Association of a Prophylactic Surgical Approach to Stage IV Small Intestinal Neuroendocrine Tumors With Survival

Kosmas Daskalakis, Andreas Karakatsanis, Ola Hessman et al. · JAMA Oncology · 2017 · 106 citations · Full text

Medicine, Oncology, Surgery +17

Clinical signs of fibrosis in small intestinal neuroendocrine tumours

Kosmas Daskalakis, Andreas Karakatsanis, Peter Stålberg et al. · British journal of surgery · 2016 · 88 citations

Medicine, Oncology, Pathology +17

Superparamagnetic iron oxide nanoparticles as the sole method for sentinel node biopsy detection in patients with breast cancer

Andreas Karakatsanis, Kosmas Daskalakis, Peter Stålberg et al. · British journal of surgery · 2017 · 82 citations

Medicine, Nuclear Medicine, Oncology +17